Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-03

AUTHORS

G. Emilien, J.-M. Maloteaux, G. Emilion

ABSTRACT

β-Adrenoceptors are members of a large family of hormone and neurotransmitter receptors that initiate their biological function by coupling to GTP-binding regulatory proteins. β-Adrenoceptors can be subdivided into two main subgroups, designated β1 and β2. Atypical β-adrenoceptors or β3-adrenoceptors, which are present on adipocytes, have been demonstrated pharmacologically. Their function in adipose tissue is currently being investigated.β2-Adrenoceptor agonists have played a key role in the treatment of asthma for some 30 years, being used for the relief and prophylaxis of symptoms. There is, however, no evidence that tolerance to the bronchodilator or anti-bronchoconstrictor effects of these drugs is responsible for the deleterious effects reported with the regular use of bronchodilators.In neuropsychiatry, β-adrenoceptor antagonists have been used for the treatment of acute stress reactions and generalised anxiety, essential tremor and prophylaxis of migraine. In general, they are effective in anxiety disorders if the somatic symptoms are not extreme. For prophylactic treatment of migraine, β-adrenoceptor antagonists such as propranolol, metoprolol, nadolol and atenolol are the drugs of first choice.In cardiology, β-adrenoceptor antagonists are an important class for the treatment of high blood pressure, arrhythmias and angina pectoris, and for prevention of myocardial infarction. With chronic treatment, they reduce mortality in hypertension and prolong survival in patients with coronary heart disease. More... »

PAGES

389-404

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002280050399

DOI

http://dx.doi.org/10.1007/s002280050399

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042256952

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9551698


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anxiety Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asthma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wyeth Ayerst Research, European CR. and D Department, 80 Avenue du Pr\u00e9sident Wilson, Puteaux-92031, Paris La D\u00e9fense, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wyeth Ayerst Research, European CR. and D Department, 80 Avenue du Pr\u00e9sident Wilson, Puteaux-92031, Paris La D\u00e9fense, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Emilien", 
        "givenName": "G.", 
        "id": "sg:person.01150666744.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150666744.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Pharmacology and Department of Neurology, Universit\u00e9 Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE", 
          "id": "http://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "Laboratory of Pharmacology and Department of Neurology, Universit\u00e9 Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maloteaux", 
        "givenName": "J.-M.", 
        "id": "sg:person.01304744241.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304744241.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Pharmacology and Department of Neurology, Universit\u00e9 Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE", 
          "id": "http://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "Laboratory of Pharmacology and Department of Neurology, Universit\u00e9 Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Emilion", 
        "givenName": "G.", 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-03", 
    "datePublishedReg": "1998-03-01", 
    "description": "Abstract\u03b2-Adrenoceptors are members of a large family of hormone and neurotransmitter receptors that initiate their biological function by coupling to GTP-binding regulatory proteins. \u03b2-Adrenoceptors can be subdivided into two main subgroups, designated \u03b21 and \u03b22. Atypical \u03b2-adrenoceptors or \u03b23-adrenoceptors, which are present on adipocytes, have been demonstrated pharmacologically. Their function in adipose tissue is currently being investigated.\u03b22-Adrenoceptor agonists have played a key role in the treatment of asthma for some 30 years, being used for the relief and prophylaxis of symptoms. There is, however, no evidence that tolerance to the bronchodilator or anti-bronchoconstrictor effects of these drugs is responsible for the deleterious effects reported with the regular use of bronchodilators.In neuropsychiatry, \u03b2-adrenoceptor antagonists have been used for the treatment of acute stress reactions and generalised anxiety, essential tremor and prophylaxis of migraine. In general, they are effective in anxiety disorders if the somatic symptoms are not extreme. For prophylactic treatment of migraine, \u03b2-adrenoceptor antagonists such as propranolol, metoprolol, nadolol and atenolol are the drugs of first choice.In cardiology, \u03b2-adrenoceptor antagonists are an important class for the treatment of high blood pressure, arrhythmias and angina pectoris, and for prevention of myocardial infarction. With chronic treatment, they reduce mortality in hypertension and prolong survival in patients with coronary heart disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002280050399", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "53"
      }
    ], 
    "keywords": [
      "\u03b2-adrenoceptor antagonists", 
      "\u03b2-adrenoceptors", 
      "prophylaxis of symptoms", 
      "anti-bronchoconstrictor effects", 
      "prophylaxis of migraine", 
      "atypical \u03b2-adrenoceptors", 
      "high blood pressure", 
      "coronary heart disease", 
      "treatment of asthma", 
      "\u03b22-adrenoceptor agonists", 
      "\u03b2-adrenoceptor agonists", 
      "current therapeutic uses", 
      "acute stress reactions", 
      "blood pressure", 
      "angina pectoris", 
      "chronic treatment", 
      "prolong survival", 
      "prophylactic treatment", 
      "myocardial infarction", 
      "heart disease", 
      "neurotransmitter receptors", 
      "adipose tissue", 
      "essential tremor", 
      "somatic symptoms", 
      "Abstract\u03b2-Adrenoceptors", 
      "antagonist", 
      "anxiety disorders", 
      "first choice", 
      "regular use", 
      "generalised anxiety", 
      "therapeutic uses", 
      "prophylaxis", 
      "bronchodilators", 
      "treatment", 
      "migraine", 
      "agonists", 
      "symptoms", 
      "deleterious effects", 
      "stress reactions", 
      "main subgroups", 
      "drugs", 
      "pectoris", 
      "hypertension", 
      "asthma", 
      "infarction", 
      "patients", 
      "arrhythmias", 
      "propranolol", 
      "mortality", 
      "regulatory proteins", 
      "nadolol", 
      "disease", 
      "metoprolol", 
      "cardiology", 
      "hormone", 
      "atenolol", 
      "prevention", 
      "receptors", 
      "tremor", 
      "biological functions", 
      "disorders", 
      "key role", 
      "survival", 
      "adipocytes", 
      "neuropsychiatry", 
      "subgroups", 
      "tissue", 
      "relief", 
      "\u03b21", 
      "anxiety", 
      "effect", 
      "years", 
      "\u03b22", 
      "large family", 
      "evidence", 
      "function", 
      "protein", 
      "role", 
      "GTP", 
      "tolerance", 
      "pressure", 
      "use", 
      "family", 
      "members", 
      "potential", 
      "choice", 
      "uses", 
      "reaction", 
      "class", 
      "important class"
    ], 
    "name": "Current therapeutic uses and potential of \u03b2-adrenoceptor agonists and antagonists", 
    "pagination": "389-404", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042256952"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002280050399"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9551698"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002280050399", 
      "https://app.dimensions.ai/details/publication/pub.1042256952"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_297.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002280050399"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002280050399'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002280050399'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002280050399'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002280050399'


 

This table displays all metadata directly associated to this object as RDF triples.

191 TRIPLES      20 PREDICATES      122 URIs      114 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002280050399 schema:about N24f5c118ede54ccd95695e8d6bdae075
2 N5a0848c6d4824f02a43ff73e8b2dc7b6
3 N7e892a898d364ba3b459c209734f0ad6
4 N80cc766cce904675ba611152dee33295
5 Naf2e0c2f589a418298e3faecb40d21d9
6 Nfa839f9014f241e6851acda388e5938a
7 anzsrc-for:11
8 anzsrc-for:1102
9 schema:author N8c8eed318eef4d84bab5bb86f6f1530f
10 schema:datePublished 1998-03
11 schema:datePublishedReg 1998-03-01
12 schema:description Abstractβ-Adrenoceptors are members of a large family of hormone and neurotransmitter receptors that initiate their biological function by coupling to GTP-binding regulatory proteins. β-Adrenoceptors can be subdivided into two main subgroups, designated β1 and β2. Atypical β-adrenoceptors or β3-adrenoceptors, which are present on adipocytes, have been demonstrated pharmacologically. Their function in adipose tissue is currently being investigated.β2-Adrenoceptor agonists have played a key role in the treatment of asthma for some 30 years, being used for the relief and prophylaxis of symptoms. There is, however, no evidence that tolerance to the bronchodilator or anti-bronchoconstrictor effects of these drugs is responsible for the deleterious effects reported with the regular use of bronchodilators.In neuropsychiatry, β-adrenoceptor antagonists have been used for the treatment of acute stress reactions and generalised anxiety, essential tremor and prophylaxis of migraine. In general, they are effective in anxiety disorders if the somatic symptoms are not extreme. For prophylactic treatment of migraine, β-adrenoceptor antagonists such as propranolol, metoprolol, nadolol and atenolol are the drugs of first choice.In cardiology, β-adrenoceptor antagonists are an important class for the treatment of high blood pressure, arrhythmias and angina pectoris, and for prevention of myocardial infarction. With chronic treatment, they reduce mortality in hypertension and prolong survival in patients with coronary heart disease.
13 schema:genre article
14 schema:isAccessibleForFree false
15 schema:isPartOf N0a25e99fe3c74888a6010d8cc6c927f2
16 N98b56c000cbc4925a811e00cd47d2f26
17 sg:journal.1054337
18 schema:keywords Abstractβ-Adrenoceptors
19 GTP
20 acute stress reactions
21 adipocytes
22 adipose tissue
23 agonists
24 angina pectoris
25 antagonist
26 anti-bronchoconstrictor effects
27 anxiety
28 anxiety disorders
29 arrhythmias
30 asthma
31 atenolol
32 atypical β-adrenoceptors
33 biological functions
34 blood pressure
35 bronchodilators
36 cardiology
37 choice
38 chronic treatment
39 class
40 coronary heart disease
41 current therapeutic uses
42 deleterious effects
43 disease
44 disorders
45 drugs
46 effect
47 essential tremor
48 evidence
49 family
50 first choice
51 function
52 generalised anxiety
53 heart disease
54 high blood pressure
55 hormone
56 hypertension
57 important class
58 infarction
59 key role
60 large family
61 main subgroups
62 members
63 metoprolol
64 migraine
65 mortality
66 myocardial infarction
67 nadolol
68 neuropsychiatry
69 neurotransmitter receptors
70 patients
71 pectoris
72 potential
73 pressure
74 prevention
75 prolong survival
76 prophylactic treatment
77 prophylaxis
78 prophylaxis of migraine
79 prophylaxis of symptoms
80 propranolol
81 protein
82 reaction
83 receptors
84 regular use
85 regulatory proteins
86 relief
87 role
88 somatic symptoms
89 stress reactions
90 subgroups
91 survival
92 symptoms
93 therapeutic uses
94 tissue
95 tolerance
96 treatment
97 treatment of asthma
98 tremor
99 use
100 uses
101 years
102 β-adrenoceptor agonists
103 β-adrenoceptor antagonists
104 β-adrenoceptors
105 β1
106 β2
107 β2-adrenoceptor agonists
108 schema:name Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists
109 schema:pagination 389-404
110 schema:productId N3ba11d9ba4df47abbdc808b3c707454b
111 N52a136f726594bc2bbe721c78a598c50
112 N83e98748124f4c1cbc89cfcc03cd4c3c
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042256952
114 https://doi.org/10.1007/s002280050399
115 schema:sdDatePublished 2022-09-02T15:48
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher N7fdecee08ad34ae1a61e318e32a0eb1f
118 schema:url https://doi.org/10.1007/s002280050399
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N0a25e99fe3c74888a6010d8cc6c927f2 schema:issueNumber 6
123 rdf:type schema:PublicationIssue
124 N24f5c118ede54ccd95695e8d6bdae075 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Heart Diseases
126 rdf:type schema:DefinedTerm
127 N3ba11d9ba4df47abbdc808b3c707454b schema:name pubmed_id
128 schema:value 9551698
129 rdf:type schema:PropertyValue
130 N52a136f726594bc2bbe721c78a598c50 schema:name dimensions_id
131 schema:value pub.1042256952
132 rdf:type schema:PropertyValue
133 N5a0848c6d4824f02a43ff73e8b2dc7b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Adrenergic beta-Antagonists
135 rdf:type schema:DefinedTerm
136 N6fb14d4955ed49ff9cb89183bd780612 rdf:first N746e90dec0a848eaaac60bb8fc2f9102
137 rdf:rest rdf:nil
138 N746e90dec0a848eaaac60bb8fc2f9102 schema:affiliation grid-institutes:grid.48769.34
139 schema:familyName Emilion
140 schema:givenName G.
141 rdf:type schema:Person
142 N7e892a898d364ba3b459c209734f0ad6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Humans
144 rdf:type schema:DefinedTerm
145 N7fdecee08ad34ae1a61e318e32a0eb1f schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N80cc766cce904675ba611152dee33295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Adrenergic beta-Agonists
149 rdf:type schema:DefinedTerm
150 N83e98748124f4c1cbc89cfcc03cd4c3c schema:name doi
151 schema:value 10.1007/s002280050399
152 rdf:type schema:PropertyValue
153 N8c8eed318eef4d84bab5bb86f6f1530f rdf:first sg:person.01150666744.25
154 rdf:rest Nd52917e571584af484e0817f2d91bf3c
155 N98b56c000cbc4925a811e00cd47d2f26 schema:volumeNumber 53
156 rdf:type schema:PublicationVolume
157 Naf2e0c2f589a418298e3faecb40d21d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Asthma
159 rdf:type schema:DefinedTerm
160 Nd52917e571584af484e0817f2d91bf3c rdf:first sg:person.01304744241.36
161 rdf:rest N6fb14d4955ed49ff9cb89183bd780612
162 Nfa839f9014f241e6851acda388e5938a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Anxiety Disorders
164 rdf:type schema:DefinedTerm
165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
166 schema:name Medical and Health Sciences
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
169 schema:name Cardiorespiratory Medicine and Haematology
170 rdf:type schema:DefinedTerm
171 sg:journal.1054337 schema:issn 0031-6970
172 1432-1041
173 schema:name European Journal of Clinical Pharmacology
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.01150666744.25 schema:affiliation grid-institutes:None
177 schema:familyName Emilien
178 schema:givenName G.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150666744.25
180 rdf:type schema:Person
181 sg:person.01304744241.36 schema:affiliation grid-institutes:grid.48769.34
182 schema:familyName Maloteaux
183 schema:givenName J.-M.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304744241.36
185 rdf:type schema:Person
186 grid-institutes:None schema:alternateName Wyeth Ayerst Research, European CR. and D Department, 80 Avenue du Président Wilson, Puteaux-92031, Paris La Défense, France, FR
187 schema:name Wyeth Ayerst Research, European CR. and D Department, 80 Avenue du Président Wilson, Puteaux-92031, Paris La Défense, France, FR
188 rdf:type schema:Organization
189 grid-institutes:grid.48769.34 schema:alternateName Laboratory of Pharmacology and Department of Neurology, Université Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE
190 schema:name Laboratory of Pharmacology and Department of Neurology, Université Catholique de Louvain and Cliniques Universitaires Saint Luc, B-1200 Brussels, Belgium, BE
191 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...